AMICUS THERAPEUTICS, INC. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Amicus Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Amicus Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 299M shares, a 2.76% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 299M +8.02M +2.76% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 296M +9.44M +3.29% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 296M +12.9M +4.54% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 294M +12.5M +4.44% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 291M +9.78M +3.48% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 287M +6.54M +2.33% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 283M +3.17M +1.13% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 281M +2.2M +0.79% Dec 31, 2022 10-K 2024-02-28
Q3 2022 281M +2.3M +0.83% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 280M +13.9M +5.22% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 280M +14.1M +5.31% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 279M +16.8M +6.43% Dec 31, 2021 10-K 2023-03-01
Q3 2021 279M +19M +7.31% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 267M +8.31M +3.22% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 266M +8.56M +3.32% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 262M +6.65M +2.6% Dec 31, 2020 10-K 2022-02-24
Q3 2020 260M +4.83M +1.9% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 258M +3.71M +1.46% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 257M +27.3M +11.8% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 255M +66M +34.9% Dec 31, 2019 10-K 2021-03-01
Q3 2019 255M +65.5M +34.6% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 255M +65.5M +34.6% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 230M +42.2M +22.5% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 189M +22.4M +13.4% Dec 31, 2018 10-K 2020-03-02
Q3 2018 189M +23.8M +14.4% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 189M +45.7M +31.9% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 188M +45.1M +31.6% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 167M +24.3M +17% Dec 31, 2017 10-K 2019-02-28
Q3 2017 165M +23.2M +16.3% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 143M +8.96M +6.67% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 143M +17.6M +14.1% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 143M +17.7M +14.1% Dec 31, 2016 10-K 2018-03-01
Q3 2016 142M +17.7M +14.2% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 134M +16M +13.6% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 125M +28.8M +29.9% Mar 31, 2016 10-Q 2016-05-03
Q4 2015 125M +29.5M +30.8% Dec 31, 2015 10-K/A 2017-03-03
Q3 2015 125M +45.4M +57.2% Sep 30, 2015 10-Q 2015-11-04
Q2 2015 118M +45.5M +62.4% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 96.4M +32M +49.8% Mar 31, 2015 10-Q 2015-05-05
Q4 2014 95.6M +33.6M +54.2% Dec 31, 2014 10-K 2016-02-29
Q3 2014 79.3M +29.6M +59.7% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 72.9M +23.2M +46.8% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 64.3M +14.7M +29.6% Mar 31, 2014 10-Q 2014-05-05
Q4 2013 62M +12.3M +24.9% Dec 31, 2013 10-K 2015-03-03
Q3 2013 49.6M +271K +0.55% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 49.6M +3.25M +7.02% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 49.6M +3.26M +7.02% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 49.6M +15M +43.2% Dec 31, 2012 10-K 2014-03-03
Q3 2012 49.4M +14.7M +42.4% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 46.4M +11.8M +34.1% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 46.4M Mar 31, 2012 10-Q 2012-05-11
Q4 2011 34.7M +145K +0.42% Dec 31, 2011 10-K 2013-03-13
Q3 2011 34.7M Sep 30, 2011 10-Q 2011-11-02
Q2 2011 34.6M Jun 30, 2011 10-Q 2011-08-11
Q4 2010 34.5M Dec 31, 2010 10-K 2012-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.